<p>(<b>A</b>) In vivo cytokine secretion after i.p. administration of 2 µg α-GalCer in 200 µl of PBS to healthy, non-terminal and terminal sick 5T33MM mice. Serum was collected during a time course, responses were followed by determining IFN-γ and IL-4 levels by ELISA (mean ± SD is shown from 5 mice in each group). (<b>B</b>) Kaplan-Meier survival assay. Mice were intravenously injected with a single dose of matured DCs (6×10<sup>5</sup> cell/mouse) loaded with α-GalCer (100 ng/mL) or unloaded at the same day of inoculation with 5T33MM cells (n = 8 mice/group, p = 0.0366). Vehicle mice had an average survival of 22 days, α-GalCer treated mice 29 days.</p
<p>BALB/c mice were immunized subcutaneously twice with 10 µg of D1ED III in PBS or in combination w...
<p>Sera were collected from WT or Dectin-2KO mice on day 14 after PPV immunization. These mice recei...
<p>C57BL/6 mice were intravenously injected with α-GalCer, OCH, or PBS. Serum samples were collected...
<p>Mice were intranasally administered with vehicle or α-GalCer. Two hours later, BALF was collected...
<p><b>A</b>. Lung iNKT cells were confirmed by PBS/CD1d tetramers and TCR-β staining in WT mice trea...
<p>αGalCer (2 µg/mouse) was administered i.v. to TRAMP (white circles) and WT (black circles) litter...
<p>Mice were immunized with GPI peptide and then treated with either DMSO or α-GalCer and euthanized...
<p><b>A</b>. Timeline of the OVA immunization/challenge protocol and the names of the treatment grou...
<p>Both wild-type and <i>Clec4f−/−</i> littermates were treated with α-GalCer (1 µg/mouse) intraveno...
<p>A. Histopathological analysis using the hematoxylin-eosin (H&E) staining and periodic acid-Schiff...
<p><b>(A, upper panel)</b> Frequency of iNKTs in liver and spleen during the course of the disease, ...
<p>HFCD mice and CD mice were injected i.v. with α-GalCer and the serum levels of cytokines at 6 h a...
<p>Jα18<sup>−/−</sup> mice and BALB/c mice (n = 10) were intranasally infected with a lethal dose (3...
<p>Mice were immunized with GPI peptide and treated with either DMSO or α-GalCer. Mice were euthaniz...
<p>(<b>A–C</b>) Total thymocytes were left unstimulated or stimulated with PMA (50 ng/ml) and ionomy...
<p>BALB/c mice were immunized subcutaneously twice with 10 µg of D1ED III in PBS or in combination w...
<p>Sera were collected from WT or Dectin-2KO mice on day 14 after PPV immunization. These mice recei...
<p>C57BL/6 mice were intravenously injected with α-GalCer, OCH, or PBS. Serum samples were collected...
<p>Mice were intranasally administered with vehicle or α-GalCer. Two hours later, BALF was collected...
<p><b>A</b>. Lung iNKT cells were confirmed by PBS/CD1d tetramers and TCR-β staining in WT mice trea...
<p>αGalCer (2 µg/mouse) was administered i.v. to TRAMP (white circles) and WT (black circles) litter...
<p>Mice were immunized with GPI peptide and then treated with either DMSO or α-GalCer and euthanized...
<p><b>A</b>. Timeline of the OVA immunization/challenge protocol and the names of the treatment grou...
<p>Both wild-type and <i>Clec4f−/−</i> littermates were treated with α-GalCer (1 µg/mouse) intraveno...
<p>A. Histopathological analysis using the hematoxylin-eosin (H&E) staining and periodic acid-Schiff...
<p><b>(A, upper panel)</b> Frequency of iNKTs in liver and spleen during the course of the disease, ...
<p>HFCD mice and CD mice were injected i.v. with α-GalCer and the serum levels of cytokines at 6 h a...
<p>Jα18<sup>−/−</sup> mice and BALB/c mice (n = 10) were intranasally infected with a lethal dose (3...
<p>Mice were immunized with GPI peptide and treated with either DMSO or α-GalCer. Mice were euthaniz...
<p>(<b>A–C</b>) Total thymocytes were left unstimulated or stimulated with PMA (50 ng/ml) and ionomy...
<p>BALB/c mice were immunized subcutaneously twice with 10 µg of D1ED III in PBS or in combination w...
<p>Sera were collected from WT or Dectin-2KO mice on day 14 after PPV immunization. These mice recei...
<p>C57BL/6 mice were intravenously injected with α-GalCer, OCH, or PBS. Serum samples were collected...